Hematopoietic Engraftment of Fanconi Anemia Patients through 3 Years after Gene Therapy
Paula Rı́o(Centre for Biomedical Network Research on Rare Diseases), Juan A. Bueren(Centro de Investigación Biomédica en Red), Anne Galy(Centre National de la Recherche Scientifique), Raquel Hladun(Vall d'Hebron Institut de Recerca), Albert Català(Hospital Sant Joan de Déu Barcelona), Eva Heredero Gálvez(Hospital Municipal de Badalona), Susana Navarro(Centre for Biomedical Network Research on Rare Diseases), Omaira Alberquilla(Cipher Gene (China)), Thierry Leblanc(Jet Propulsion Laboratory), Nagore García de Andoín(Biogipuzkoa Health Research Institute), Yari Giménez(Centre for Biomedical Network Research on Rare Diseases), Francisco J Roman‐Rodriguez(Centre for Biomedical Network Research on Rare Diseases), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), José C. Segovia(Unidades Centrales Científico-Técnicas), Julián Sevilla(University of Southern Denmark), Manfred Schmidt(Centre National de la Recherche Scientifique), Eva Merino(Centre for Biomedical Network Research on Rare Diseases), Jean Soulier(Centre National de la Recherche Scientifique), Rebeca Sánchez‐Domínguez, Rosa María Pérez Yáñez(Instituto de Salud Carlos III), José Antonio Casado(Centre for Biomedical Network Research on Rare Diseases), Ricardo López Almaraz(BioCruces Health research Institute), Jordi Surrallés(Universitat Autònoma de Barcelona), Jonathan D. Schwartz(Temple University), Wei Wang(Central South University), Roser Pujol(Universitat Autònoma de Barcelona), Jordi Barquinero(Vall d'Hebron Institut de Recerca), François Lefrère(Hôpital Necker-Enfants Malades), Marina Cavazzana(Université Rennes 2)
Cited by 1
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k